News | News By Subject | News by Disease News By Date | Search News

Tumor (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
FDA Demands Karyopharm (KPTI) Stop Enrollment of All Selinexor Trials     3/14/2017
Seattle Genetics (SGEN), Immunomedics (IMMU) Ink $2 Billion Tumor Drug Deal     2/13/2017
Bay Area’s CBT Pharma Plans to Launch 2 Phase I Trials in 2017     12/22/2016
How Fast Can Kite Pharma (KITE) File for an Approval of its Lead CAR-T?     10/20/2016
Daiichi Sankyo and Plexxikon Suspend Phase III Trial of Drug for Rare Tendon Cancer     10/19/2016
Juno (JUNO), Five Prime (FPRX) are Quiet Winners at AACR     4/25/2016
Kite Pharma (KITE) Cancer Therapy Responses in Solid Tumors Continued in Small Trial, NCI Review Halts Patient Enrollment     4/18/2016
Fluorescence Lighting Up Clinical Research     3/3/2016
Forty Seven Launches with Half of $75 Million Series A Backed by Google (GOOG) and 100+ Patents     2/26/2016
Analyst Questions High Cost of T Cell Therapies as Potential Frontline Treatment for Blood Cancers     2/25/2016
Armed with $50 Million from Google (GOOG), Celgene (CELG) and More, ARMO BioSciences Eyes Next-Gen Cancer Drug Combos     2/11/2016
Sneak Peak of Five Prime (FPRX)'s Prelim Phase I Tumor Data Leaves Investors Happy     1/22/2016
Analysts Take a Peek at Pfizer (PFE)'s 2015 Drug Sales, With a Few Surprises     12/31/2015
SoCal Biotech BioAtla Forges a $1 Billion Antibody Partnership with Pfizer (PFE)     12/9/2015
Daiichi Sankyo and Bay Area’s Plexxikon Inc. Win Breakthrough Tag for Pexidbartini     11/2/2015

News from Around the Web
New Technique Provides Quick Tumor Diagnosis During Brain Surgeries, University of Michigan Study     2/9/2017
Miniature Brain And Skull Found Inside 16-Year-Old Girl's Ovary, Shiga Medical Centre Study     1/11/2017
How Strata Oncology Plans To Sequence 100K Tumors For Free     12/22/2016
SurgVision Displays Tumors During Surgery     12/14/2016
New Invention: An Implantable Capsule For Killing Tumors, Houston Methodist Research Institute Study     12/13/2016
Deep Learning Algorithms Applied to Tracking Tumor Development, Fraunhofer Institute For Medical Image Computing Study     11/16/2016
Excess Weight Linked To 8 More Cancers, Washington University School of Medicine Reveals     8/31/2016
Magnetic Bacteria Carry Anti-Cancer Drugs To Tumor, Polytechnique Montréal Nanorobotics Laboratory Study     8/23/2016
Patch Delivers Drug, Gene, And Light-Based Therapy To Tumor Sites, MIT Study     7/26/2016
"Smart" Nanoparticle Called Pearls A Promising Gem To Target, Treat Tumors, University of Toronto Study     7/25/2016
Brain Tumor Risk Linked To The Wealthier, Better-Educated, Study Published In BMJ     6/21/2016
Wireless Injectable Computer Could Deliver More Accurate Reading Of Tumor Pressure, University of Michigan Study     6/17/2016
New MRI Contrast Agent Spots Malignant Tissues, Tokyo Institute Of Technology Study     6/15/2016
Chemical 'Sponges' Designed To Soak Up Toxic Cancer-Fighting Drugs After Targeting Tumors, Lawrence Berkeley National Laboratory Reveals     6/8/2016
Portable Probes Hunt Down Cancer Cells During Surgery, University Hospital of Lausanne Study Reveals     6/8/2016

Press Releases
St. Jude Children's Research Hospital Release: Caution Needed For Drugs In Development For Most Common Malignant Pediatric Brain Tumor     3/22/2017
OncoSec Medical's Intratumoral Plasmid IL-12 Demonstrates Effectiveness At Enhancing Tumor Immunogenicity In Preclinical Tumor Models     3/22/2017
European Group On Tumour Markers (EGTM) Updated Guidelines Recommend Agendia BV's Mammaprint Test With Highest Level 1A Clinical Evidence     3/22/2017
Bristol-Myers Squibb Canada (BMY) Release: Manitoba To Cover Immuno-Oncology Treatment OPDIVO (Nivolumab) For Three Tumour Types     3/15/2017
Agena Biosciences Introduces New Lung And Colon Cancer Panels For Detection Of Somatic Mutations From Liquid Biopsies And Solid Tumor Tissues     3/15/2017
Roche (RHHBY) Launches The Cobas EGFR Mutation Test V2 For Use With Either Plasma Or Tumor Tissue Samples     3/14/2017
Hutchison China MediTech (Chi-Med) Presented Sulfatinib Neuroendocrine Tumors Phase Ib/II Results At The 14th Annual Conference Of European Neuroendocrine Tumor Society     3/10/2017
Siamab Announces Publication Of New Preclinical Data In The Journal mAbs Describing Its Novel Monoclonal Antibody Approach To Targeting The Tumor-Associated Carbohydrate Antigen STn     3/8/2017
Cyclacel Pharma (CYCC)’s CDK Inhibitor CYC065 Causes Anaphase Catastrophe, A Novel Cancer-Specific Mechanism Of Action, In Research Published In JNCI     3/7/2017
Advanced Accelerator Applications Announces Presentation Of Quality Of Life Findings From NETTER-1 Phase III Study At ENETS     3/6/2017
Exelixis (EXEL) Announces Clinical Trial Collaboration With Roche (RHHBY) To Evaluate Cabozantinib And Atezolizumab In Locally Advanced Or Metastatic Solid Tumors     2/27/2017
Mologen (MOLGF.PK): First Combination Data Of TLR9 Agonists Enandim With Checkpoint Inhibitor In Preclinical Tumor Models     2/27/2017
CBT Pharma Presents Data Demonstrating Anti-Tumor Activity Of Its Programmed Death-1 Antibody, CBT-501, At ASCO-SITC Clinical Oncology Symposium     2/23/2017
Exelixis (EXEL) Announces Phase 1 Trial Results For Cabozantinib In Combination With Nivolumab With Or Without Ipilimumab In Refractory Metastatic Urothelial Carcinoma And Other Genitourinary Tumors     2/20/2017
Hutchison China MediTech (Chi-Med) Initiates A Phase II Study Of Savolitinib In Pulmonary Sarcomatoid Carcinoma     2/20/2017